Overview

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, two-arm, one-sequence, cross-over study to evaluate the safety and pharmacokinetic interaction after oral concomitant administration of tadalafil and dutasteride in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Dongkook Pharmaceutical Co., Ltd.
Treatments:
Dutasteride
Tadalafil